Federal Appeals Court Rejects Hearing On Cox-2 Patent

Law360, New York (July 6, 2004, 12:00 AM EDT) -- The U.S. Court of Appeals for the Federal Circuit has denied the University of Rochester’s request for a hearing by the court’s full panel on the validity of a patent for cox-2 inhibitors such as Pfizer’s $3 billion Celebrex drug.

University of Rochester scientists claim they discovered the gene that produces the cox-2 enzyme and described the role it plays in producing inflammation and pain. Cox-2 inhibitors are drugs that can relieve pain and inflammation without causing cramps and bleeding.

The university applied for the patent...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.